Allurion Gastric Balloon Offers New Hope for Obesity Treatment in Indonesia

PT Regenesis Indonesia continues to demonstrate its unwavering commitment to advancing modern health solutions in Indonesia, particularly in the critical area of weight management. Their participation in The 8th Bandung Nutri Wellness 2026 serves as a platform to showcase the Allurion Gastric Balloon, a groundbreaking global technology that offers a new paradigm in tackling obesity.

Since its introduction in mid-2024, the Allurion Gastric Balloon has emerged as a significant innovation. It represents a leap forward in intragastric balloon therapy, offering a non-endoscopic, non-anesthetic, and entirely non-invasive approach. This makes it a safer and more comfortable alternative for individuals seeking effective weight loss solutions, integrating seamlessly with the necessary long-term lifestyle changes required for sustained health transformations.

President Director of PT Regenesis Indonesia, Emmy Noviawati, articulated the company's vision, stating that the presence of Allurion in Indonesia aligns with Regenesis's goal of delivering relevant global solutions to contemporary health challenges. The increasing trust from various medical specialists in Indonesia validates Allurion's credibility as a tool to combat the rising rates of obesity. Regenesis is not merely introducing a product; it is fostering an ecosystem that supports responsible clinical implementation, education, and collaboration.

The inclusion of Allurion as a workshop topic at The 8th Bandung Nutri Wellness further underscores its importance in the medical community. This forum, bringing together health practitioners, academics, and clinical nutrition professionals, provides a vital space for discussing modern health challenges like obesity. The workshop, titled "Intragastric Balloon Therapy in Advanced Obesity Management," offered a comprehensive look at integrating lifestyle interventions with technological advancements, reflecting Indonesia's growing focus on holistic and evidence-based approaches to public health.

“

Kepercayaan lintas dokter spesialis di Indonesia terhadap Allurion Gastric Balloon menunjukkan bahwa teknologi ini telah diterima sebagai salah satu solusi yang kredibel dalam membantu menekan angka obesitas. Regenesis tidak hanya menghadirkan inovasi, tetapi juga membangun ekosistem edukasi, kolaborasi, dan implementasi klinis yang bertanggung jawab dan berkelanjutan.